What is the development history of tumor biotherapy?

Tumor biotherapy is a new method of treating autoimmune tumors. It is the fourth cancer treatment mode after surgery, radiotherapy, and chemotherapy, and is also an important part of comprehensive cancer treatment. The occurrence of tumors itself is systemic and related to genetic factors, gene mutations, epigenetic changes, environmental factors, etc. With the development of health and the extension of life cycle, the number of elderly people over 80 years old continues to increase, and their cell metabolism ages and gradually becomes abnormal. This is also a period when cancer is most common.

All nascents can independently sponsor these experiments as long as the laboratory can claim credits through the patent holder system or during the project. Biopharmaceuticals have a lot of room to grow as long as they get a license before applying. Biopharmaceuticals and immunotherapy led to major discoveries in the 1950s, 1960s and 1970s, including two Nobel Prize winners last year. It is believed that the country’s follow-up policies are in place and the prospects for biological treatment of tumors are quite broad.

Nanotechnology is developing small particles to deliver drugs more directly to cancer cells. After characterizing the overall function of the cell by measuring thousands of molecules, gene expression analysis is performed to identify aggressive and less aggressive cancers. Proteomics technology can be used to identify biochemical markers and protein expression characteristics, which can be used for personalized treatment. Taking cancer research to the molecular level will bring unprecedented benefits.

Tumor is a new organism formed in the human body under the stimulation of various factors. Can be divided into benign tumors and malignant tumors. Benign tumors have clear borders, slow growth, no cellular atypia, and no distant organ metastasis, and generally do not require treatment. Malignant tumors have unclear boundaries, grow invasively, and have obvious atypia in tumor cells. As tumors progress, distant organ metastasis occurs, requiring timely intervention and treatment. Possible treatment options for malignant tumors at different locations and stages are also different. If the cancer is relatively early, surgical treatment can generally be considered, such as gastric cancer, esophageal cancer, lung cancer, etc. Early surgical treatment has good results. In addition, comprehensive treatment such as radiotherapy and chemotherapy is required after surgery. Cancer is also a systemic disease and must be treated comprehensively.